Figure 4.
The quantification of ROS generated in sorafenib-treated hiPSC-CMs. Mitochondria-damage-induced reactive oxygen species (ROS) production can be detected in both sorafenib-treated hiPSC-CMs. The imbalance between mitochondrial reactive oxygen species overexpression and removal leads to oxidative damage affecting cellular components. Since the cardiomyocyte is a highly energetic organ, it is vulnerable to damage caused by oxidative stress. p-values, ** p < 0.01, *** p < 0.001, compared with vehicle.
